USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
11-Jun-2014
Global
Market Research
MA03-01-00-00-00
LS00098-GL-MR_16939
This study explores Western Europe’s dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 2014–2018 forecast period. A list of key sequencing service providers for each country or region is included.
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
Market Definitions
Evolution of Molecular Genetic Testing
DNA Testing Ecosystem—Where Does NGS Fit?
Market Age
Market Segmentation
Western European Market Perspective
Defining Healthcare Trends in the Future
Procurement Process
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Market Restraints
Market Impact of Top 8 Trends
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Percent Revenue Forecast by Product Type
Revenue Forecast by Product Type
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Installed Base by Country
Number of Facilities
Market Outlook in Western Europe
Percent Revenue Forecast by Reagent Segment
Revenue Forecast by Reagent Segment
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Western European NGS Instruments—Market Share
Western European NGS Instruments—Market Share Analysis
Western European NGS Instruments—Market Share Analysis (continued)
Western European NGS Instruments—Market Share Analysis (continued)
Illumina—Overview
Product Analysis—Illumina
Applications
Life Technologies—Overview
Product Analysis—Life Technologies
Applications
Roche (454 Life Sciences)—Overview
Product Analysis—Roche
Applications
Pacific Biosciences—Overview
Product Analysis—Pacific Biosciences
Applications
Top Competitors
Top Competitors (continued)
Top Competitors (continued)
Top Competitors (continued)
Market Analysis
Western Europe Key Findings
PEST Analysis
Percent Sales Breakdown by Country
UK—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Germany—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
France—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Spain—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Italy—Revenue Forecast
Revenue Forecast Discussion
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
Benelux—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
Scandinavia—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
NGS Instruments—Service Providers
NGS Instruments—Service Providers (continued)
NGS Instruments—Service Providers (continued)
The Last Word—3 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
List of Commercial Providers for Genetic Tests
List of Commercial Providers for Genetic Tests (continued)
List of Commercial Providers for Genetic Tests (continued)
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Additional Sources of Information
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | MA03-01-00-00-00 |
| Is Prebook | No |
Analysis of the Western European Next Generation Sequencing (NGS) Market
$4,950.00
Special Price $3,712.50 save 25 %